On this page
TAF2
TATA-box binding protein associated factor 2
TAF2 is located on the long (q) arm of chromosome 8, at band 8q24.12. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 8 in the library →Available at Jeen Health
Clinical tests that include this
Overview
TAF2 is located on chromosome 8 and encodes TATA-box binding protein associated factor 2, a subunit of the general transcription factor TFIID. This multi-protein complex plays a central role in the first steps of gene expression, positioning RNA polymerase II at gene promoters and helping to regulate which genes are switched on in different cell types.
Transcription initiation is a tightly controlled process that determines how cells respond to developmental signals and environmental changes. The TAF2 protein contributes to this regulatory network by participating in the recognition of core promoter elements and the assembly of the pre-initiation complex. Disruption of TAF2 function has the potential to affect gene expression programmes across multiple cellular pathways.
What the gene does
The TAF2 protein serves as one of several TAF subunits within the TFIID complex, which acts as a molecular scaffold during transcription initiation. TFIID binds to promoter regions upstream of genes, particularly recognising the TATA box sequence when present, and recruits additional transcription factors and RNA polymerase II to form the complete initiation machinery.
TAF2 contributes to the structural integrity of TFIID and participates in protein-protein interactions that stabilise the assembly of the transcription apparatus. The coordinated action of TAF subunits allows TFIID to integrate signals from various regulatory proteins, enabling cells to fine-tune gene expression in response to growth signals, stress conditions and developmental cues. By helping to control which genes are transcribed and at what levels, TAF2 indirectly influences numerous cellular processes including cell division, differentiation and metabolic regulation.
Video: Genetics 101
Chromosome location
TAF2 is located on the long arm of chromosome 8 at position 24.12 (8q24.12). This chromosomal region contains numerous genes involved in cellular regulation and development. The precise number of exons and the full genomic structure of TAF2 have not been comprehensively detailed in all public databases, though the gene spans a segment of DNA that encodes the full-length protein subunit.
Protein structure
Domain architecture has not been experimentally characterised in detail for this protein. The TAF2 polypeptide is understood to contain regions that mediate interactions with other TAF subunits and with components of the transcription machinery, but specific functional domains have not been mapped to defined amino acid boundaries in widely available structural databases.
Key variants
Genetic variants in TAF2 may alter the protein's ability to participate in transcription initiation, potentially affecting gene expression patterns. Pathogenic variants could disrupt protein folding, interfere with subunit assembly within TFIID, or impair interactions with regulatory factors. The clinical significance of most TAF2 variants has not been extensively characterised, and ongoing research continues to clarify which changes have functional consequences.
Sample of pathogenic variants
3 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
g.(?_120743013)_(120845082_?)del | - | Pathogenic | ★☆☆☆ | Microcephaly-thin corpus callosum-intellectual disability syndrome |
c.1945T>C | p.Trp649Arg | Pathogenic | - | Microcephaly-thin corpus callosum-intellectual disability syndrome |
c.2380T>A | p.Tyr794Asn | Pathogenic/Likely pathogenic | - | Microcephaly-thin corpus callosum-intellectual disability syndrome |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
TAF2 has not been conclusively linked to specific inherited conditions in large-scale clinical genetics databases at present. Research into the functional consequences of TAF2 variants is ongoing, and future studies may identify associations between alterations in this gene and developmental or regulatory disorders. The broad role of TAF2 in transcription suggests that severe loss of function could have wide-ranging effects on cellular health.
No disease links recorded for this gene in our reference set.
UK clinical status
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What does the TAF2 gene do?
TAF2 provides instructions for a protein subunit of TFIID, a complex that initiates gene transcription by RNA polymerase II. It helps assemble the molecular machinery needed to produce messenger RNA from DNA templates.
Is TAF2 tested on NHS genetic panels?
TAF2 is not currently included on NHS Genomic Medicine Service gene panels. Testing availability may change as research advances and clinical associations are established.
How is TAF2 inherited?
The inheritance pattern for TAF2-related conditions has not been definitively established. Depending on the nature of pathogenic variants and their functional effects, inheritance could follow different patterns, which would be clarified through genetic counselling if a variant is identified.